Neuroplast
Neuroplast is a series a startup based in Netherlands. 1 investor tracked.
About Neuroplast
Neuroplast is a company headquartered in the Netherlands. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Neuroplast is a clinical-stage biotechnology company based in Geleen, Netherlands, developing Neuro-Cells®, an autologous stem cell platform to treat neurodegeneration caused by trauma, disease, and ageing. The company is advancing cell therapy candidates for conditions including spinal cord injury, traumatic brain injury, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Explore Neuroplast's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.